Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-07 3:24 pm Purchase |
2021-12-31 | 13G | Disruptive Acquisition Corporation I DISA |
Hudson Bay Capital Management LP | 2,025,615 7.370% |
2,025,615 (New Position) |
Filing History |
| 2022-02-07 3:22 pm Purchase |
2021-12-31 | 13G | Data Knights Acquisition Corp. DKDCA |
Hudson Bay Capital Management LP | 949,974 7.860% |
949,974 (New Position) |
Filing History |
| 2022-02-07 3:17 pm Unchanged |
2021-12-31 | 13G | Aptorum Group Limited APM |
Hudson Bay Capital Management LP | 92,308 6.540% |
0 (Unchanged) |
Filing History |
| 2022-02-07 3:07 pm Purchase |
2021-12-31 | 13G | Aesther Healthcare Acquisition Corp. AEHA |
Hudson Bay Capital Management LP | 600,000 5.660% |
600,000 (New Position) |
Filing History |
| 2022-02-04 4:29 pm Sale |
2021-12-31 | 13G | Protagenic Therapeutics, Inc. PTIX |
Hudson Bay Capital Management LP | 0 0.000% |
-19,517 (Position Closed) |
Filing History |
| 2022-02-04 4:26 pm Sale |
2021-12-31 | 13G | Cosmos Health Inc. COSM |
Hudson Bay Capital Management LP | 34,337 4.720% |
-6,047 (-14.97%) |
Filing History |
| 2022-02-04 4:23 pm Purchase |
2021-12-31 | 13G | Synthetic Biologics, Inc. SYN |
Hudson Bay Capital Management LP | 260,870 1.940% |
38,968 (+17.56%) |
Filing History |
| 2022-02-04 4:19 pm Unchanged |
2021-12-31 | 13G | Peraso Inc. PRSO |
Hudson Bay Capital Management LP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2022-02-04 4:17 pm Purchase |
2021-12-31 | 13G | Viveve Medical, Inc. VIVE |
Hudson Bay Capital Management LP | 258,064 2.380% |
17,075 (+7.09%) |
Filing History |
| 2022-02-04 4:15 pm Unchanged |
2021-12-31 | 13G | Tenax Therapeutics, Inc. TENX |
Hudson Bay Capital Management LP | 486 2.990% |
0 (Unchanged) |
Filing History |
| 2022-02-04 4:10 pm Purchase |
2021-12-31 | 13G | Plus Therapeutics, Inc. PSTV |
Hudson Bay Capital Management LP | 36,667 3.460% |
1,302 (+3.68%) |
Filing History |
| 2022-02-04 4:08 pm Purchase |
2021-12-31 | 13G | LM Funding America, Inc. LMFA |
Hudson Bay Capital Management LP | 30,000 1.390% |
30,000 (New Position) |
Filing History |
| 2022-02-04 4:06 pm Unchanged |
2021-12-31 | 13G | Helbiz, Inc. HLBZ |
Hudson Bay Capital Management LP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2022-02-04 4:03 pm Unchanged |
2021-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Hudson Bay Capital Management LP | 1,719 3.970% |
0 (Unchanged) |
Filing History |
| 2022-02-04 3:59 pm Unchanged |
2021-12-31 | 13G | Can-Fite BioPharma Ltd. CANF |
Hudson Bay Capital Management LP | 2,438,415 4.080% |
0 (Unchanged) |
Filing History |
| 2022-02-04 3:56 pm Unchanged |
2021-12-31 | 13G | Arcadia Biosciences, Inc. RKDA |
Hudson Bay Capital Management LP | 22,251 3.860% |
0 (Unchanged) |
Filing History |
| 2022-02-04 3:42 pm Sale |
2021-12-31 | 13G | Yield10 Bioscience, Inc. YTEN |
Hudson Bay Capital Management LP | 417 0.200% |
-9,479 (-95.79%) |
Filing History |
| 2022-02-04 3:39 pm Purchase |
2021-12-31 | 13G | Timber Pharmaceuticals, Inc. TMBR |
Hudson Bay Capital Management LP | 51,497 3.880% |
24,788 (+92.81%) |
Filing History |
| 2022-02-04 3:37 pm Sale |
2021-12-31 | 13G | WiSA Technologies, Inc. WISA |
Hudson Bay Capital Management LP | 16 1.480% |
-28 (-63.46%) |
Filing History |
| 2022-02-04 3:35 pm Sale |
2021-12-31 | 13G | SRAX, Inc. SRAX |
Hudson Bay Capital Management LP | 909,088 3.360% |
-1,753,968 (-65.86%) |
Filing History |